Lucrative Prize for Life Scientists

Three Silicon Valley entrepreneurs are offering $3 million to scientists demonstrating excellence in biology and medical research.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, IMAGES_OF_MONEYEleven biologists were yesterday (February 20) rewarded with $3 million each as the first recipients of the Breakthrough Prize in Life Sciences—a new award set up by a trio of Silicon Valley big shots to recognize and support research into understanding and curing diseases.

The award—which offers more than twice the cash of a Nobel Prize—is organized by Facebook founder Mark Zuckerberg, Google co-founder Sergei Brin, and venture capitalist Yuri Milner. The idea was to make a statement that life scientists are important, to raise awareness of their achievements, and to encourage a new generation of molecular biologists and geneticists, Milner told The Guardian. “Young people will hopefully get the message that not only the careers in sports or entertainment can get public recognition,” he said.

This year’s recipients, who are free to use the money as they please, include Cornelia Bargmann, who investigates neural circuits and animal behavior at Rockefeller University; Titia de Lange, also at Rockefeller, who works on telomeres; Robert Weinberg of the Massachusetts Institute of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development